This 4th edition of the Symposium on ATP1A3 in disease seeks to accomplish several key objectives:
- To share the latest research findings in Alternating Hemiplegia of Childhood (AHC), Rapid Onset Dystonia-Parkinsonism (RDP), & CAPOS (Cerebellar ataxia — areflexia — pes cavus — optic atrophy — sensorineural hearing loss) Syndrome.
- To discuss various symptomology and what has (or could) be done to address them to improve quality of life for patients NOW
- To discuss what steps we need to take today to be ready for clinical trials when we find candidate compounds for treatment
- To involve new research and clinical teams in the important work ongoing
We want to express our gratitude for the crucial and generous effort of the family support groups in the organization of this Symposium.
We look forward to seeing you in Washington, DC Metro this August!
Jeff Wuchich (Cure AHC), David Goldstein (Columbia University), Erin Heinzen (Columbia University), Mohamad Mikati (Duke University) Chairpersons